Search by Drug Name or NDC
NDC 44523-0535-02 Sodium Sulfacetamide, Sulfur 100; 20 mg/g; mg/g Details
Sodium Sulfacetamide, Sulfur 100; 20 mg/g; mg/g
Sodium Sulfacetamide, Sulfur is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BioComp Pharma, Inc.. The primary component is SULFACETAMIDE SODIUM; SULFUR.
Product Information
| NDC | 44523-0535 |
|---|---|
| Product ID | 44523-535_09921c9b-ad4d-c843-e063-6394a90a3dc3 |
| Associated GPIs | 90059903203718 |
| GCN Sequence Number | 066049 |
| GCN Sequence Number Description | sulfacetamide sodium/sulfur CREAM (G) 10 %-2 % TOPICAL |
| HIC3 | Q5S |
| HIC3 Description | TOPICAL SULFONAMIDES |
| GCN | 28227 |
| HICL Sequence Number | 003344 |
| HICL Sequence Number Description | SULFACETAMIDE SODIUM/SULFUR |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Sulfacetamide, Sulfur |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SULFACETAMIDE SODIUM, SULFUR |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 100; 20 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | SULFACETAMIDE SODIUM; SULFUR |
| Labeler Name | BioComp Pharma, Inc. |
| Pharmaceutical Class | Sulfonamide Antibacterial [EPC], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 44523-0535-02 (44523053502)
| NDC Package Code | 44523-535-02 |
|---|---|
| Billing NDC | 44523053502 |
| Package | 57 g in 1 BOTTLE, PLASTIC (44523-535-02) |
| Marketing Start Date | 2011-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |